Scribe Therapeutics
Dirigeants
Voir l'organigramme avec ses 14 principaux dirigeants
Biographies les plus recherchées chez Scribe Therapeutics
- Benjamin Oakes, Chief Executive Officer and Director
- Behzad Aghazadeh, Director
- Vijay Pande, Director
Changements de dirigeants chez Scribe Therapeutics
- Maria Mirotsou, a rejoint l'entreprise comme Vice President of Discovery Biology (publié le 21 décembre 2023).
- Aarif Khakoo, a rejoint l'entreprise comme Chief Scientific Officer and Head of Research and Development (publié le 21 décembre 2023).
Créer une alerte
pour suivre les mouvements de dirigeants chez Scribe Therapeutics.
Biotechnologie
Scribe Therapeutics a 2 294 concurrents dont Eurofins (Luxembourg), Lonza (Suisse) et Adaptive Phage Therapeutics (Etats—Unis).
Actualités en fusion/acquisition en Biotechnologie.
- Lycia Therapeutics vient d'annoncer une levée de fonds de 107 millions de dollars. (publié le 15 mai 2024).
- Attovia Therapeutics vient d'annoncer une levée de fonds de 150 millions de dollars. (publié le 14 mai 2024).
- Bruker has announced the acquisition of NanoString Technologies (publié le 13 mai 2024).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par Scribe Therapeutics
- CRISPR technologies fuelling haematological innovations
- Press Release – Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual
- News: CRISPR Partnerships Propel Precision Medicine - CRISPR Medicine
- Press Release – Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting • Scribe
- Press Release – Scribe Therapeutics to Participate in the Leerink Partners Global Biopharma Conference • Scribe
- Press Release – Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target • Scribe
- Press Release – Scribe Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Scribe
- Press Release – Scribe Therapeutics Appoints Dr. Aarif Khakoo as Chief Scientific Officer and Head of Research and Development, and Dr. Maria Mirotsou as Vice President of Discovery Biology • Scribe
- A decade later, biotech’s CRISPR revolution is still going strong
- Press Release – Scribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular Diseases • Scribe
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Scribe Therapeutics
- Scribe Therapeutics sur Wikipédia, Google News & Yahoo Finance en 1-click
- Scribe Therapeutics sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Carl Gordon 
Appelez Scribe Therapeutics au +1 510...
